A
American Research Institute | Cutler Bay, FL
Research site
(Unclaimed)
Site insights
Top conditions
Top treatments
Ozanimod
Relamorelin
Lanifibranor
TVB-2640
Data sourced from clinicaltrials.gov
Work at this site?
CTV for research professionals allows users to enhance their siteās profile, add contact information, and more.
Active trials
3 of 9 total trials
This Phase 3 study is conducted to evaluate lanifibranor in adults with NASH and liver fibrosis histological stage F2 or F3
Enrolling
NASH - Nonalcoholic Steatohepatitis
Drug: Placebo
Drug: IVA337
This is a study to demonstrate the effect of oral ozanimod as maintenance therapy in participants with moderately to severely active Crohn's Disease.
Active, not recruiting
Crohn Disease
Other: Placebo
Drug: Ozanimod
This is an extension study to evaluate safety and efficacy of ozanimod in participants with moderately to severely active Crohn's Disease.
Active, not recruiting
Crohn Disease
Drug: Ozanimod
Trial sponsors
I
S
V
Clinical trials
Research sites
Resources
Legal
Ā© Copyright 2024 Veeva Systems